![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Y Kitada, A Narimatsu, R Suzuki, M Endoh and N Taira
Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan.
MCI-154 is a new positive inotropic agent with vasodilating property. Experiments were carried out in the canine isolated right ventricular muscle in order to elucidate whether or not cyclic AMP is involved in the positive inotropic effect (PIE) of MCI-154. MCI-154 (10(-7) to 10(- 4) M) produced a concentration-dependent PIE amounting to 75% of the maximal effect of isoproterenol. MCI-154 did not affect the time to peak tension and had a tendency to shorten the relaxation time and total duration of contraction. Pindolol, reserpine-pretreatment or tetrodotoxin did not modify the PIE of MCI-154. MCI-154 increased the cyclic AMP levels only at 3 X 10(-4) M, whereas CI-914, of which chemical structure is similar to that of MCI-154, elevated definitely the cyclic AMP at the lower concentrations (10(-5) to 10(-4) M). Carbachol at a concentration known to decrease markedly the PIE of amrinone, milrinone and papaverine, did not affect the PIE of MCI-154. MCI-154 inhibited the activity of a crude phosphodiesterase (PDE) from the canine ventricular muscle and it enhanced the PIE of isoproterenol, which implied the involvement of cyclic AMP. However, the maximal inhibition of PDE by MCI-154 remained less than 18%. Amrinone, milrinone and papaverine inhibited more potently the PDE activity than MCI-154. These results suggest that the elevation of cyclic AMP levels is only partially involved in the PIE of MCI-154 in the canine right ventricular muscle, and that MCI-154 may have novel mechanisms of action different from those of amrinone, milrinone and CI-914 that are largely cyclic AMP-dependent.
This article has been cited by other articles:
|
|
 |
|
  S. Takahashi, S. Cho, T. Hara, H. Ureshino, S. Tomiyasu, and K. Sumikawa The Interaction of MCI-154, a Calcium Sensitizer, and Isoflurane on Systemic and Coronary Hemodynamics in Chronically Instrumented Dogs Anesth. Analg., January 1, 2004; 98(1): 30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Senzaki, T. Isoda, N. Paolocci, U. Ekelund, J. M. Hare, and D. A. Kass Improved Mechanoenergetics and Cardiac Rest and Reserve Function of In Vivo Failing Heart by Calcium Sensitizer EMD-57033 Circulation, March 7, 2000; 101(9): 1040 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Eto, K. Hashimoto, and H. Nakaya Preferential inhibition of IKr by MCI-154, a putative cardiotonic Ca2+ sensitizer, in guinea pig atrial cells Cardiovasc Res, June 1, 1998; 38(3): 685 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Onishi, K. Sekioka, R. Ishisu, Y. Abe, H. Tanaka, M. Nakamura, Y. Ueda, and T. Nakano MCI-154, a Ca2+ sensitizer, decreases the oxygen cost of contractility in isolated canine hearts Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1688 - H1695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Teramura, T. Yamakado, M. Maeda, and T. Nakano Effects of MCI-154, a Calcium Sensitizer, on Left Ventricular Systolic and Diastolic Function in Pacing-Induced Heart Failure in the Dog Circulation, February 4, 1997; 95(3): 732 - 739. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
